- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Ophthalmology
Volume 2013 (2013), Article ID 257381, 5 pages
Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization
1Department of Ophthalmology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
2Department of Biomedical statistics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
Received 25 June 2012; Accepted 1 February 2013
Academic Editor: Edward Manche
Copyright © 2013 Taku Wakabayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Xu, Y. Wang, Y. Li et al., “Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study,” Ophthalmology, vol. 113, no. 7, pp. 1134.e1–1134.e11, 2006.
- A. Iwase, M. Araie, A. Tomidokoro, T. Yamamoto, H. Shimizu, and Y. Kitazawa, “Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi study,” Ophthalmology, vol. 113, no. 8, pp. 1354–1362, 2006.
- C. C. Klaver, R. C. Wolfs, J. R. Vingerling, et al., “Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study,” Archives of Ophthalmology, vol. 116, no. 5, pp. 653–658, 1998.
- S. A. Cotter, R. Varma, M. Ying-Lai, S. P. Azen, and R. Klein, “Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye study,” Ophthalmology, vol. 113, no. 9, pp. 1574–1582, 2006.
- T. Yoshida, K. Ohno-Matsui, K. Yasuzumi et al., “Myopic choroidal neovascularization: a 10-year follow-up,” Ophthalmology, vol. 110, no. 7, pp. 1297–1305, 2003.
- A. Otani, H. Takagi, H. Oh, S. Koyama, M. Matsumura, and Y. Honda, “Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes,” Investigative Ophthalmology and Visual Science, vol. 40, no. 9, pp. 1912–1920, 1999.
- J. Tong, W. Chan, D. T. L. Liu et al., “Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization,” American Journal of Ophthalmology, vol. 141, no. 3, pp. 456–462, 2006.
- H. Sakaguchi, Y. Ikuno, F. Gomi, et al., “Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia,” British Journal of Ophthalmology, vol. 91, no. 2, pp. 161–165, 2007.
- I. Yamamoto, A. H. Rogers, E. Reichel, P. A. Yates, and J. S. Duker, “Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia,” British Journal of Ophthalmology, vol. 91, no. 2, pp. 157–160, 2007.
- W. Chan, T. Y. Y. Lai, D. T. L. Liu, and D. S. C. Lam, “Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study,” Ophthalmology, vol. 114, no. 12, pp. 2190–2196, 2007.
- M. Gharbiya, F. Allievi, L. Mazzeo, and C. B. Gabrieli, “Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results,” American Journal of Ophthalmology, vol. 147, no. 1, pp. 84.e1–93.e1, 2009.
- Y. Ikuno, K. Sayanagi, K. Soga et al., “Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results,” American Journal of Ophthalmology, vol. 147, no. 1, pp. 94.e1–100.e1, 2009.
- T. Wakabayashi, Y. Ikuno, F. Gomi, T. Hamasaki, and Y. Tano, “Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia,” American Journal of Ophthalmology, vol. 148, no. 4, pp. 591–596, 2009.
- W. Chan, T. Y. Y. Lai, K. Chan et al., “Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia,” Retina, vol. 28, no. 9, pp. 1308–1313, 2008.
- Y. Ikuno and Y. Tano, “Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography,” Investigative Ophthalmology and Visual Science, vol. 50, no. 8, pp. 3876–3880, 2009.
- L. P. Aiello, A. J. Brucker, S. Chang et al., “Evolving guidelines for intravitreous injections,” Retina, vol. 24, supplement 5, pp. S3–S19, 2004.
- A. P. Dempster, N. M. Laird, and D. B. Rubin, “Maximum likelihood from incomplete data via the EM algorithm (with discussion),” Journal of the Royal Statistical Society B, vol. 39, no. 1, pp. 1–38, 1977.
- M. S. Wolynetz, “Maximum likelihood estimation from confined and censored normal data,” Applied Statistics, vol. 28, pp. 185–195, 1979.
- L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” The New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994.
- A. P. Adamis, J. W. Miller, M. T. Bernal, et al., “Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 118, no. 4, pp. 445–450, 1994.
- A. Kvanta, P. V. Algvere, L. Berglin, and S. Seregard, “Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor,” Investigative Ophthalmology and Visual Science, vol. 37, no. 9, pp. 1929–1934, 1996.
- R. C. Tripathi, J. Li, B. J. Tripathi, Chalam, and A. P. Adamis, “Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma,” Ophthalmology, vol. 105, no. 2, pp. 232–237, 1998.
- O. Sawada, H. Kawamura, M. Kakinoki, T. Sawada, and M. Ohji, “Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy,” Archives of Ophthalmology, vol. 125, no. 10, pp. 1363–1366, 2007.
- M. J. Tolentino, J. W. Miller, E. S. Gragoudas, K. Chatzistefanou, N. Ferrara, and A. P. Adamis, “Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate,” Archives of Ophthalmology, vol. 114, no. 8, pp. 964–970, 1996.
- S. Duke-Elder, “Pathological refractive errors,” in System of Ophthalmology, vol. 5 of Ophthalmic Optics and Refraction, pp. 297–373, Mosby, St. Louis, Mo, USA, 1970.
- H. Ohno, “Electron microscopic studies of myopic retinochoroidal atrophies 1. Choroidal changes,” Folia Ophthalmologica Japonica, vol. 43, pp. 1244–1253, 1983 (Japanese).
- N. Matsuo, S. Okabe, E. Hasegawa, and S. Okamoto, Report of Research Committee on Chorioretinal Degenerations, The Ministry of Health and Welfare of Japan, Tokyo, Japan, (Japanese), 1978.
- Y. F. Shih, M. E. Fitzgerald, T. T. Norton, et al., “Reduction in choroidal blood flow occurs in chicks wearing goggles that induce eye growth toward myopia,” Current Eye Research, vol. 12, no. 3, pp. 219–227, 1993.
- T. Tokoro, “Diffuse chorioretinal atrophy,” in Atlas of Posterior Fundus Changes in Pathological Myopia, pp. 7–14, Springer, Tokyo, Japan, 1998.
- T. Wakabayashi and Y. Ikuno, “Choroidal filling delay in choroidal neovascularisation due to pathological myopia,” British Journal of Ophthalmology, vol. 94, no. 5, pp. 611–615, 2010.
- H. Noma, H. Funatsu, M. Yamasaki, et al., “Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion,” Eye, vol. 22, no. 1, pp. 42–48, 2008.